China Gene Therapy Market to 2032
Overview
The China Gene Therapy Market is expected to reach a 1,507.59 USD Billion by 2032 and is projected to grow at a CAGR of 30.27% from 2025 to 2032.
Revenue, 2024 (USD Billion)
342.71
Forecast, 2032 (USD Billion)
1,507.59
CAGR, 2024 - 2032
30.27%
Report Coverage
China
China Gene Therapy Market 2018-2032 USD Billion
China Gene Therapy Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 342.71 USD Billion
- Projected Market Size (2032): 1,507.59 USD Billion
- CAGR (2025-2032): 30.27%
Key Findings of China Gene Therapy Market
- The China Gene Therapy Market was valued at 342.71 USD Billion in 2024.
- The China Gene Therapy Market is likely to grow at a CAGR of 30.27% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Viral Vector in Vector Segment accounted for the largest share of the market with a revenue of 267.90 USD Billion
- The fastest growing segment Oncological Disorders in Application Segment grew Fastest with a CAGR of 33.30% during the forecast period from 2024 to 2032.
China Gene Therapy Market Scope
China Gene Therapy Market Segmentation & Scope
Method
- In-Vivo
- Ex-Vivo
Vector
- Non-Viral Vector
- Viral Vector
Application
- Other Diseases
- Neurological Disorders
- Rare Diseases
- Infectious Disease
- Cardiovascular Diseases
- Oncological Disorders
End User
- Others
- Research Institutes
- Hospitals
- Cancer Institutes
China Gene Therapy Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 342.71 USD Billion |
| Market Value in 2032 | 1,507.59 USD Billion |
| CAGR (2025-2032) | 30.27% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Method,Vector,Application,End User |
Regional Insights:
-
Leading Market (2024-2032): China, leading in terms of revenue 342.71 USD Billion in 2024
- Key Country: China, leading in terms of revenue with value of 342.71 USD Billion in 2024.
Segments and Scope
-
China Gene Therapy Market to 2032, By Method
- Ex-Vivo is the largest segment in China Gene Therapy Market to 2032 with a revenue of 261.79 USD Billion in the year 2024.
- Ex-Vivo is the Fastest growing segment in China Gene Therapy Market to 2032 with a Growth rate of 31.47 % in forecast period 2025-2032.
-
China Gene Therapy Market to 2032, By Vector
- Viral Vector is the largest segment in China Gene Therapy Market to 2032 with a revenue of 267.90 USD Billion in the year 2024.
- Viral Vector is the Fastest growing segment in China Gene Therapy Market to 2032 with a Growth rate of 31.50 % in forecast period 2025-2032.
-
China Gene Therapy Market to 2032, By Application
- Oncological Disorders is the largest segment in China Gene Therapy Market to 2032 with a revenue of 162.26 USD Billion in the year 2024.
- Oncological Disorders is the Fastest growing segment in China Gene Therapy Market to 2032 with a Growth rate of 33.30 % in forecast period 2025-2032.
-
China Gene Therapy Market to 2032, By End User
- Cancer Institutes is the largest segment in China Gene Therapy Market to 2032 with a revenue of 153.20 USD Billion in the year 2024.
- Cancer Institutes is the Fastest growing segment in China Gene Therapy Market to 2032 with a Growth rate of 32.06 % in forecast period 2025-2032.
China Gene Therapy Market Company Share Analysis
| Company Name |
|
||
| Oxford Biomedica | |||
| Novartis AG | |||
| Kite Pharma Inc. | |||
| Biogen | |||
| Bristol-Myers Squibb Company | |||
China Gene Therapy Market Geographical Sales Distribution, 2018-2032 USD Billion
China Gene Therapy Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The China Gene Therapy Market is segmented based on Segmentation Method,Vector,Application,End User.
China Gene Therapy Market was valued at USD 342.71(Revenue in USD Billion) in 2021.
China Gene Therapy Market is projected to grow at a CAGR of 30.27% during the forecast period of 2024 to 2032.
The Viral Vector segment is expected to dominate the China Gene Therapy Market, holding a largest market share of 267.90 USD Billion in 2024
China Gene Therapy Market Scope
China Gene Therapy Market Segmentation & Scope
Method
- In-Vivo
- Ex-Vivo
Vector
- Non-Viral Vector
- Viral Vector
Application
- Other Diseases
- Neurological Disorders
- Rare Diseases
- Infectious Disease
- Cardiovascular Diseases
- Oncological Disorders
End User
- Others
- Research Institutes
- Hospitals
- Cancer Institutes
Frequently Asked Questions
The China Gene Therapy Market is segmented based on Segmentation Method,Vector,Application,End User.
China Gene Therapy Market was valued at USD 342.71(Revenue in USD Billion) in 2021.
China Gene Therapy Market is projected to grow at a CAGR of 30.27% during the forecast period of 2024 to 2032.
The estimated market value of the China Gene Therapy Market for final year is USD 1,507.59 (USD Billion).
China Gene Therapy Market Company Profiling
Frequently Asked Questions
The China Gene Therapy Market is segmented based on Segmentation Method,Vector,Application,End User.
China Gene Therapy Market was valued at USD 342.71(Revenue in USD Billion) in 2021.
China Gene Therapy Market is projected to grow at a CAGR of 30.27% during the forecast period of 2024 to 2032.
The estimated market value of the China Gene Therapy Market for final year is USD 1,507.59 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.